Clinical Review: A national network improved IBD care through sustained collaboration and data collection.
Background & Rationale
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, demands a multidisciplinary approach to optimise patient outcomes. Historically, IBD care has been fragmented, lacking seamless integration between specialist centres, general practitioners, and other healthcare providers. The German IBD competence network (CompNet IBD) was established in 1999 to address these challenges, aiming to improve the quality of care through collaborative research, standardised data collection, and knowledge transfer across all levels of IBD healthcare provision. This paper reports on 25 years of CompNet IBD’s operation, detailing its structure, achievements, and impact on IBD management in Germany.
Study Design
This work represents a comprehensive retrospective analysis of the CompNet IBD’s activities over a 25-year period, from its inception in 1999 to 2024. The analysis encompassed a descriptive assessment of the network’s structure, organisation, and evolving tasks. Data were extracted from the network’s established databases, including longitudinal patient data collected from participating centres, annual reports, publications resulting from network research, and outcome measures related to network activities. The authors detail expansions in focus from initial research priorities to include innovations in digital health, biobanking, and patient education.
Patient Population
The CompNet IBD network involves over 140 participating centres, including gastroenterology departments in university hospitals, private practices, and regional hospitals throughout Germany. The network’s database includes longitudinal data from over 35,000 IBD patients. Data collection reflects a geographically diverse representation of the German IBD population, although specific demographic details regarding the patient cohort were not the primary focus of this descriptive, network-level evaluation. The network also incorporates participation from patient advocacy groups and allied healthcare professionals.
Key Findings
Initial priorities centred on establishing a nationwide registry for IBD patients. The network’s registry now contains detailed clinical data, including disease characteristics, treatment histories, endoscopic findings, and patient-reported outcomes. Over the 25-year period, approximately 850 publications have resulted from research conducted within the CompNet IBD framework. The network facilitated the development of standardised treatment algorithms for IBD, incorporating current clinical guidelines and best practice recommendations.
Crucially, CompNet IBD established a biobank containing over 60,000 biological samples, providing resources for translational research initiatives, including biomarker discovery and personalised medicine approaches. Digital health initiatives, launched more recently, have focused on developing and implementing telemedicine solutions for remote patient monitoring and support. The network facilitated over 600 educational events for healthcare professionals, contributing to knowledge dissemination and upskilling. A core outcome measure tracked was the increased proportion of patients receiving guideline-concordant care, increasing from 65% in 2000 to 88% in 2023.
Discussion
The longevity and sustained activity of CompNet IBD demonstrate the feasibility and value of a national, collaborative network in improving IBD care. The established registry serves as a valuable resource for epidemiological studies and quality improvement initiatives. The network’s contribution to research, education, and the development of treatment algorithms has likely influenced clinical practice patterns across Germany. Incorporating patient perspectives through advocacy group involvement was another key strength.
Ongoing challenges involve ensuring data quality, maintaining participant engagement, and adapting to evolving technologies and treatment modalities. The network reports an increasing focus on integrating real-world data and utilising artificial intelligence to enhance clinical decision-making. Mean time to diagnosis remains a focus for ongoing improvement. Reported tolerability of established network infrastructure is considered high, with retention rates of participating centres exceeding 90% over a 10-year period.
Authors’ Conclusions
The authors conclude that the CompNet IBD has successfully provided a sustained platform for improving IBD care in Germany through interdisciplinary collaboration and robust data collection over the past 25 years. They emphasise the network’s ongoing relevance in addressing emerging challenges and advancing the field of IBD management, positioning it as a model for other countries seeking to establish similar collaborative structures.
Reference
Bokemeyer B, Plachta-Danielzik S, Helwig U, Beuchert P, Schreiber S. Competence network inflammatory bowel diseases in Germany: 25 years of interdisciplinary and cross-sectoral research and knowledge transfer across all levels of IBD care. Therapeutic advances in gastroenterology. 2026;10(1):17562848261431187. DOI: 10.1177/17562848261431187.